Nishaki Mehta, MD
Clinical Cardiac Electrophysiology · Royal Oak, MINPI 1417182544
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $93,390 of the $132,601 with a category attached, or 70.4%. 13 manufacturers reported payments, led by Medtronic at 42.8% of the total. 2025 is the largest year on record at $54,836, 6.3 times the $8,736 reported in 2019. Among clinical cardiac electrophysiology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 276 payments — averaging $480.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$57K
- Boston Scientific$45K
- Abbott$21K
- Altathera Pharmaceuticals LLC$4K
- Sanofi-aventis U.S. LLC$3K
- Biosense Webster, Inc.$2K
- plus $866 from 7 others
Across 5 payments — averaging $2621.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$13K
- Abbott$607
What the payments were for
- Consulting fees$8,5256%
- Speaking & faculty fees$93,39070%
- Travel & lodging$22,78017%
- Food & beverage$7,9066%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 128 | $56,812 |
| Boston Scientific | 49 | $45,078 |
| Abbott | 66 | $21,097 |
| Altathera Pharmaceuticals LLC | 4 | $4,173 |
| Sanofi-aventis U.S. LLC | 1 | $2,769 |
| Biosense Webster, Inc. | 10 | $1,807 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $283 |
| Biotronik Inc. | 3 | $241 |
| Philips North America LLC | 1 | $150 |
| Abiomed | 1 | $132 |
| Cardiva Medical, Inc. | 1 | $28 |
| Pfizer | 1 | $17 |
| Novartis | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBLEM MRI S-ICD$20,625
- GENERAL - THERAPIES$14,726
- ENSITE$6,978
- ENSITE PRECISION$6,516
- Ensite Cardiac Mapping System$5,246
- Sotalol Hydrochloride$4,100
- MULTAQ$2,769
- Farapulse$2,558
- Carto 3$1,658
- AVEIR$806
- Micra$453
- AFFERA MAPPING SYSTEM$281
- ADVISOR$214
- Claria MRI$171
- Bridge$150
- Impella$132
- WATCHMAN Access System$126
- Selectra$116
- Acticor 7 VR-T DX$111
- LifeVest$102
How this compares
$132,601 in reported general payments places this provider in the 90th percentile of 105 clinical cardiac electrophysiology providers in Michigan.
See all clinical cardiac electrophysiology providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 166 | $198,716 |
| XareltoRivaroxaban | 41 | $46,520 |
| MultaqDronedarone Hcl | 19 | $31,114 |
| JardianceEmpagliflozin | 21 | $16,906 |
| Repatha SureclickEvolocumab | 28 | $15,254 |
| Amiodarone Hcl | 58 | $2,390 |
| Metoprolol Succinate | 69 | $1,209 |
| Flecainide Acetate | 30 | $1,052 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 27 | $765 |
| Rosuvastatin Calcium | 33 | $584 |
| Carvedilol | 29 | $403 |
| Atorvastatin Calcium | 25 | $394 |
| Amlodipine Besylate | 17 | $172 |
| Metoprolol Tartrate | 26 | $151 |
| Losartan Potassium | 16 | $123 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $17 | $198,716166 claims |
| Sanofi-aventis U.S. LLCMultaq | $2,769 | $31,11419 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 105 clinical cardiac electrophysiology providers in Michigan.
Other clinical cardiac electrophysiology in Royal Oak
- Mahmoud AhmedRoyal Oak$20K
- Randy LiebermanDetroit$1.2M
- Asim YunusSaginaw$236K
- Jackson LiangAnn Arbor$229K
- Ryan CunnaneAnn Arbor$218K
- Dipak ShahSouthfield$194K
- Rakesh LatchamsettyBrighton$165K
- Ilana KutinskyTroy$138K
- Andre GauriGrand Rapids$126K
- Daniel AlyeshAnn Arbor$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.